SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899243-00-000701
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
8
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 226164
2 FORM OF 8.42% SENIOR SECURED NOTE EX-4.2 7926
3 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT EX-10.13 29119
4 FORM OF NOTE PURCHASE AGREEMENT EX-10.14 172765
5 SUBSIDIARIES OF THE REGISTRANT EX-21.1 2380
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP EX-23.1 494
7 CONSENT OF ARTHUR ANDERSEN LLP EX-23.2 984
8 FINANCIAL DATA SCHEDULE EX-27 2069
  Complete submission text file 0000899243-00-000701.txt   444105
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26190 | Film No.: 587749
SIC: 8093 Services-Specialty Outpatient Facilities, NEC